Menu
Currency
GWAS Study

New susceptibility loci in MYL2, C12orf51 and OAS1 associated with 1-h plasma glucose as predisposing risk factors for type 2 diabetes in the Korean population.

Go MJ, Hwang JY, Kim YJ et al.

23575436 PubMed ID
GWAS Study Type
14232 Participants
33 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

GM
Go MJ
HJ
Hwang JY
KY
Kim YJ
HO
Hee Oh J
KY
Kim YJ
HK
Heon Kwak S
SP
Soo Park K
LJ
Lee J
KB
Kim BJ
HB
Han BG
CM
Cho MC
CY
Cho YS
LJ
Lee JY
Chapter II

Abstract

Summary of the research findings

Most recently, 1-h hyperglycemia has been recognized as an additional risk factor for type 2 diabetes. To date, previous genome-wide association studies for glycemic traits have a limited impact on the fasting state and 2-h plasma glucose level in an oral glucose challenge. To identify genetic susceptibility in different stages of glucose tolerance, we performed a meta-analysis for glycemic traits including 1-h plasma glucose (1-hPG) from 14 232 non-diabetic individuals in the Korean population. Newly implicated variants (MYL2, C12orf51 and OAS1) were found to be significantly associated with 1-hPG. We also demonstrated associations with gestational diabetes mellitus. Our results could provide additional insight into the genetic variation in the clinical range of glycemia.

7,696 Korean ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

14232
Total Participants
GWAS
Study Type
Yes
Replicated
6,536 Korean ancestry individuals
Replication Participants
East Asian
Ancestry
Republic of Korea
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.